Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate
Maria De Santis(Medical University of Vienna), Matteo Della Porta(University of Milan), Antonio Tonutti(Humanitas University), Nicla Manes(Wellcome Sanger Institute), Chiara Milanesi(Istituti di Ricovero e Cura a Carattere Scientifico), Gabriele Todisco(Humanitas University), Arturo Bonometti(Humanitas University), Rossella Caselli(IRCCS Humanitas Research Hospital), Francesca Motta(University of Modena and Reggio Emilia), Serena Albertazzi(IRCCS Humanitas Research Hospital), Carlo Selmi(University of Milan)
Cited by 3
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617